May 252017
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– USA, MA – Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focusing on the development of novel tumor-targeted and immuno-oncology therapies based on its pioneering research in cancer epigenetics, today announced it has appointed Jigar Raythatha as president and chief executive officer.… => Read more

Constellation Pharmaceuticals appoints Jigar Raythatha as CEO and announces Dr Jim Audia to its Board of Directors

From:: Constellation Pharmaceuticals appoints Jigar Raythatha as CEO and announces Dr Jim Audia to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: